The Leukemia & Lymphoma Society Tees Off Their 4th Annual Links Fore Leukemia Golf Tournament |
|
|
|
Registration and check-in begins at 11a.m. with tee time at 1p.m. The event will take place on both the Talon and Raptor courses and will conclude with a catered reception on the Grayhawk grounds, with a live and silent auction. All proceeds benefit LLS’ programs of patient services, public education, financial aid and research. The original “Links Fore Leukemia” Golf Tournament started in 1997 in Dallas, Texas. It was created by Bob Barker and Jim Willis. At the age of 37, Willis lost his personal battle against leukemia just months after the inaugural tournament.
It is estimated that more than 830,000 Americans are living with blood cancer. LLS is doing their part to give them hope, by investing more than $1/2 billion in research, contributing to advances such as chemotherapy, bone marrow and stem cell transplantation and new targeted therapies. For more information and registration details please visit www.linksforeleukemia.org or contact Karen Chapman at The Leukemia & Lymphoma Society, at (602) 788 8622x26 or This e-mail address is being protected from spam bots, you need JavaScript enabled to view it . The Leukemia & Lymphoma Society
For more information on the Desert Mountain States Chapter please visit www.linksforeleukemia.org. |
The courses have been manicured and the golf clubs are ready to go for The Leukemia & Lymphoma Society’s 4th Annual Links Fore Leukemia Golf Tournament. The tournament will take place at the prestigious Grayhawk Golf Club at 8620 East Thompson Peak Parkway, in Scottsdale, Arizona on June 9th.
Barker’s goal was then to see the tournament continued in Texas, with
satellite events elsewhere. In the ensuing eleven years the tournament
has raised over $2 million, and has expanded to include both Phoenix
and Orlando, Florida.
The Leukemia & Lymphoma Society is the world's largest voluntary
health organization dedicated to funding blood cancer research,
education and patient services. LLS’ mission is to cure leukemia,
lymphoma, Hodgkin's disease and myeloma, and improve the quality of
life of patients and their families. Since its founding in 1949, LLS
has invested more than $550.8 million for research. While specifically
targeting blood cancers, LLS’ treatment advances now impact many other
forms of cancer. The Society's Home Office is based in White Plains,
NY.
